Glicojax and diabetes: Brazil’s regulator banned the product

On 2 February 2026, Brazil’s health regulator Anvisa ordered the seizure of Glicojax and prohibited its manufacture, sale, distribution, advertising and use in Brazil. Anvisa said the product’s origin was unknown and that advertising linked it to blood-glucose control, cardiovascular and metabolic support, and diabetes control. The agency said these therapeutic benefits lacked scientific substantiation and that such claims are not permitted for foods, including supplements. [1][2]

What Anvisa confirmed

The order covers all lots identified as Glicojax. The Official Gazette extract lists the company and its registration number as unknown and records the claims behind the enforcement action. This is not merely a negative customer review: Brazil’s regulator issued a sanitary prohibition based on unknown origin and unlawful therapeutic advertising. [1][2]

Why the diabetes claim matters

Dietary supplements are not medicines. Anvisa says they do not treat, prevent or cure diseases and must not be advertised as treatment. In October 2026 the agency also warned that supplement claims about treating insulin resistance can steer people away from appropriate care. Blood glucose and diabetes require clinical assessment; calling something “natural” does not turn an unidentified product into treatment. [3][4]

What the order does not establish

The official notice does not report a laboratory finding of hidden ingredients or say that an undeclared medicine was present. It also does not establish that similarly named products sold outside Brazil are the same item. We found no verified current price, bait-price evidence, or documentation that sellers pushed an expensive course by phone. We will not invent those claims. [1][2]

What to do

• Do not buy or use the Glicojax covered by Anvisa’s Brazilian prohibition. [1]
• If you have used it, keep the package and note the lot, seller and date. Speak with a health professional, especially if you have diabetes or take medicines.
• Do not stop or replace prescribed insulin or other treatment with drops, capsules or a “three-step control” promise. Anvisa says supplements do not treat diseases; diabetes care should be agreed with your care team. [3][4]
• If you see this product offered for sale in Brazil, save the listing and report it to Anvisa or local health surveillance. Check the official notice and product details in the sources below. [1][2]

Our verdict

We do not recommend the Glicojax prohibited in Brazil, and especially not as diabetes treatment. Anvisa cited unknown origin, an unidentified company in the Official Gazette, and unsupported therapeutic advertising, then prohibited all lots. There is no basis to turn that into a claim of hidden medicine or phone fraud; the official prohibition is already a clear reason to avoid the identified product.